Literature DB >> 18024366

High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis.

Pei Lin, L Jeffrey Medeiros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18024366     DOI： 10.3324/haematol.11263

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  27 in total

1.  Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.

Authors:  Onyemaechi N Okolo; Ariel C Johnson; Seongseok Yun; Stacy J Arnold; Faiz Anwer
Journal:  Immunotherapy       Date:  2017-08-03       Impact factor: 4.196

2.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 3.  Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?

Authors:  Deborah A Thomas; Susan O'Brien; Stefan Faderl; John T Manning; Jorge Romaguera; Luis Fayad; Fredrick Hagemeister; Jeffrey Medeiros; Jorge Cortes; Hagop Kantarjian
Journal:  Curr Hematol Malig Rep       Date:  2011-03       Impact factor: 3.952

Review 4.  Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.

Authors:  Ipsita Pal; Maryam Safari; Marko Jovanovic; Susan E Bates; Changchun Deng
Journal:  Curr Hematol Malig Rep       Date:  2019-08       Impact factor: 3.952

5.  The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia.

Authors:  Yan Li; Shimin Hu; Sa A Wang; Shaoying Li; Yang O Huh; Zhenya Tang; L Jeffrey Medeiros; Guilin Tang
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

Review 6.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

Review 7.  High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.

Authors:  Allison Rosenthal; Anas Younes
Journal:  Blood Rev       Date:  2016-09-30       Impact factor: 8.250

Review 8.  [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].

Authors:  M M Ott; H Horn; A Rosenwald; G Ott
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

9.  Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.

Authors:  Gabriela Gualco; Eduardo M Queiroga; Lawrence M Weiss; Claudete E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2009-01-13       Impact factor: 3.466

10.  Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.

Authors:  Leticia Quintanilla-Martinez; Daphne de Jong; Antoine de Mascarel; Eric D Hsi; Philip Kluin; Yaso Natkunam; Marie Parrens; Stefano Pileri; German Ott
Journal:  J Hematop       Date:  2009-12-22       Impact factor: 0.196
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.